Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    Open Studies | "Poxviridae Infections"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Poxviridae Infections" (9 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting IMVAMUNE® Smallpox Vaccine in Adult Healthcare Personnel at Risk for Monkeypox in the Democratic Republic of the Congo
Condition: Monkeypox Virus Infection
Intervention: Biological: IMVAMUNE®
2 Recruiting VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV
Condition: Smallpox Vaccine Adverse Reaction
Intervention: Biological: Vaccination with ACAM2000
3 Available Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure
Conditions: Smallpox;   Monkeypox
Intervention: Drug: Tecovirimat
4 Recruiting Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
Condition: Smallpox
Intervention: Biological: ACAM2000® smallpox vaccine
5 Recruiting A Dose Range-Finding Phase 2 Trial of a Botanical Drug for the Treatment of Molluscum Contagiosum in Pediatric Subjects
Condition: Molluscum Contagiosum
Interventions: Drug: 10% East Indian sandalwood oil cream;   Drug: Placebo Cream
6 Recruiting Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
Conditions: Erysipelas;   Impetigo;   Herpes Zoster;   Molluscum Contagiosum;   Warts;   Tinea;   Melanoma;   Actinic Keratosis;   Basal Cell Carcinoma;   Squamous Cell Carcinoma
Interventions: Procedure: Screening;   Device: Tele-dermatology
7 Recruiting Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Condition: Hepatocellular Carcinoma (HCC)
Interventions: Biological: Pexastimogene Devacirepvec (Pexa Vec);   Drug: Sorafenib
8 Recruiting Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
Condition: Lung Cancer
Intervention: Biological: GL-ONC1
9 Recruiting GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent Ovarian Cancer
Conditions: Ovarian Cancer;   Peritoneal Carcinomatosis;   Fallopian Tube Cancer
Intervention: Biological: GL-ONC1

Study has passed its completion date and status has not been verified in more than two years.